Approval · Notice of Compliance 17003 · 2015
ARTISS: Notice of Compliance 17003
Issued June 18, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17003
- Date
- June 18, 2015
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Hemostatic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ARTISS | 02326167 | Marketed |
Medicinal ingredients
- CALCIUM CHLORIDE 40 MCMOL per ML
- THROMBIN (HUMAN) 4 UNIT per ML
- SEALER PROTEIN (HUMAN) 125 MG per ML
- APROTININ (SYNTHETIC) 3,000 KIU per ML